Author's Correction for Ami et al., J. Virol. 79 (20) 12871-12879.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ami, Y.
Right arrow Articles by Honda, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Ami, Y.
Right arrow Articles by Honda, M.

 Previous Article  |  Next Article 

Journal of Virology, October 2006, p. 10288, Vol. 80, No. 20
0022-538X/06/$08.00+0     doi:10.1128/JVI.01681-06

AUTHOR'S CORRECTION

Priming-Boosting Vaccination with Recombinant Mycobacterium bovis Bacillus Calmette-Guérin and a Nonreplicating Vaccinia Virus Recombinant Leads to Long-Lasting and Effective Immunity

Yasushi Ami, Yasuyuki Izumi, Kazuhiro Matsuo, Kenji Someya, Masaru Kanekiyo, Shigeo Horibata, Naoto Yoshino, Koji Sakai, Katsuaki Shinohara, Sohkichi Matsumoto, Takeshi Yamada, Shudo Yamazaki, Naoki Yamamoto, and Mitsuo Honda

Division of Experimental Animal Research, AIDS Research Center, Division of Biosafety Control and Research, National Institute of Infectious Diseases, Toyama 1-23-1, Shinjuku-ku, Tokyo 162-8640, Japan; Department of Microbiology and Immunology, Iwate Medical University School of Medicine, Uchimaru 19-1, Morioka, Iwate 020-8505, Japan; Department of Host Defense, Graduate School of Medicine, Osaka City University, Osaka, Osaka 545-8585, Japan; and Department of Bacteriology, School of Dentistry, Nagasaki University, Nagasaki, Nagasaki 852-8588, Japan

Volume 79, no. 20, p. 12871-12879, 2005. Pages 12873 and 12874: We have recently recognized errors in Table 1 and Fig. 2.

Page 12873, Table 1, immunization and challenge schedule: In groups 1, 2 and 3, rBCG was primed at week 3, followed by booster immunization of rDIs at weeks 50 and 54. In groups 4 and 5, rDIs was primed at weeks 0 and 12, followed by booster immunization of rBCG at week 50. Then all animals were challenged with virulent SHIV KS661c at week 57.

Page 12874, Fig. 2: The weeks after immunization shown on the x axis in panel A should read "3, 7, 11, 19, 27, 35, 50, 53, 54, and 56." The weeks after immunization shown on the x axis in panel B should read "0, 4, 8, 16, 24, 32, 50, 52, 53, 54, and 56." Although the patterns and magnitudes of the kinetics were almost the same as the original ones, the standard deviation of the ELISPOT data at the peak response at 54 weeks after immunization was 500, which was five times more than originally reported. Spot-forming cells were counted by using a KS ELISPOT system after 35 weeks of immunization. Before that, we counted SFCs using an inverted microscope.

Page 12878, Acknowledgments, paragraph 1: Delete the last sentence of that paragraph.

These changes do not alter the conclusions of the article.

Journal of Virology, October 2006, p. 10288, Vol. 80, No. 20
0022-538X/06/$08.00+0     doi:10.1128/JVI.01681-06





This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ami, Y.
Right arrow Articles by Honda, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Ami, Y.
Right arrow Articles by Honda, M.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»